Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A John Barrett

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Best Practice & Research. Clinical Haematology|September 16, 2008
Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantationKatayoun Rezvani, A John Barrett
Pediatric Hematology and Oncology|February 1, 2013
Gauchers disease--a reappraisal of hematopoietic stem cell transplantationSawa Ito, A John Barrett
Haematologica|April 2, 2009
Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevanceA John Barrett, Elaine Sloand
Blood|April 9, 2015
The role of stem cell transplantation for chronic myelogenous leukemia in the 21st centuryA John Barrett, Sawa Ito
Tissue Engineering. Part B, Reviews|January 14, 2014
Bone marrow mesenchymal stromal cells to treat complications following allogeneic stem cell transplantationMinoo Battiwalla, A John Barrett
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2011
Is human cell therapy research caught in a mousetrap?A John Barrett, J Joseph Melenhorst
Hematology. American Society of Hematology. Education Program|February 20, 2015
Cytotoxic T lymphocytes for leukemia and lymphomaCatherine M Bollard, A John Barrett
Best Practice & Research. Clinical Haematology|May 28, 2008
Prophylaxis of acute GVHD: manipulate the graft or the environment?A John Barrett, Katarina Le Blanc
Blood|June 12, 2010
Minor histocompatibility antigen discovery: turning up the HEATRA John Barrett, J Joseph Melenhorst
Current Hematologic Malignancy Reports|April 29, 2010
Immunosuppressive therapy for myelodysplastic syndromes: refining the indicationsA John Barrett, Elaine M Sloand
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Best Practice & Research. Clinical Haematology|September 16, 2008
Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantationKatayoun Rezvani, A John Barrett
Pediatric Hematology and Oncology|February 1, 2013
Gauchers disease--a reappraisal of hematopoietic stem cell transplantationSawa Ito, A John Barrett
Haematologica|April 2, 2009
Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevanceA John Barrett, Elaine Sloand
Blood|April 9, 2015
The role of stem cell transplantation for chronic myelogenous leukemia in the 21st centuryA John Barrett, Sawa Ito
Tissue Engineering. Part B, Reviews|January 14, 2014
Bone marrow mesenchymal stromal cells to treat complications following allogeneic stem cell transplantationMinoo Battiwalla, A John Barrett
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2011
Is human cell therapy research caught in a mousetrap?A John Barrett, J Joseph Melenhorst
Hematology. American Society of Hematology. Education Program|February 20, 2015
Cytotoxic T lymphocytes for leukemia and lymphomaCatherine M Bollard, A John Barrett
Best Practice & Research. Clinical Haematology|May 28, 2008
Prophylaxis of acute GVHD: manipulate the graft or the environment?A John Barrett, Katarina Le Blanc
Blood|June 12, 2010
Minor histocompatibility antigen discovery: turning up the HEATRA John Barrett, J Joseph Melenhorst
Current Hematologic Malignancy Reports|April 29, 2010
Immunosuppressive therapy for myelodysplastic syndromes: refining the indicationsA John Barrett, Elaine M Sloand
Pageof 19